Logo courtesy Bot Image Inc. The Omaha-based MRI medical device company, Bot Image Inc., announced this month an addition to its line of software products aimed at assisting the detection of prostate ...
Certification opens the European market for the first FDA-cleared AI platform for prostate MRI interpretation. OMAHA, Neb., Oct. 27, 2025 /PRNewswire/ -- Bot Image, Inc., a leader in AI-powered ...
One of the most promising advancements is ProstatID, developed by Bot Image Inc. This AI-based technology has demonstrated remarkable success, improving prostate cancer detection rates by over 30% ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback